AMGEN INC (AMGN:NASDAQ)
$350.95 1.13 (0.323%)
Analysed AMGEN INC (AMGN:NASDAQ) News Sources
Amgen And Zai Lab Trial Tests DLL3 Combo As Valuation Looks Undemanding
14-04-2026
yahoo.com
J&J Beats Q1 Earnings & Sales Estimates, Raises 2026 Outlook
14-04-2026
yahoo.com
Morgan Stanley Raises Amgen (AMGN) Target Ahead of Q1, Truist Lifts Outlook on Pipeline Strength
13-04-2026
yahoo.com
Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight
13-04-2026
yahoo.com
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
13-04-2026
yahoo.com
Beat the Market the Zacks Way: FirstEnergy, Seanergy Maritime, Amgen in Focus
13-04-2026
yahoo.com
Jim Cramer on Regeneron (REGN): “I Think The Stock’s Breaking Out Here”
12-04-2026
yahoo.com
Assessing Amgen (AMGN) Valuation As TEPEZZA And MariTide Trial Results Draw Fresh Investor Focus
11-04-2026
yahoo.com
This Startup’s Psoriasis Drug Studies Have Lifted Its Stock
10-04-2026
yahoo.com
Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again
10-04-2026
yahoo.com
What is the current price of AMGEN INC (AMGN:NASDAQ)?
The current price of AMGEN INC (AMGN:NASDAQ) is $350.95.
AMGEN INC (AMGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMGEN INC (AMGN:NASDAQ) since the previous trading day is $1.13.
AMGEN INC (AMGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMGEN INC (AMGN:NASDAQ) since the previous trading day is 0.323%.
What is the most recent average sentiment score for AMGEN INC (AMGN:NASDAQ)?
The most recent average sentiment score for AMGEN INC (AMGN:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for AMGEN INC (AMGN:NASDAQ)?
The most recent sentiment for AMGEN INC (AMGN:NASDAQ) is .
SEC-8K** Filing Available For AMGEN INC (AMGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.